Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INMD · against 437 other Healthcare companies of similar size
Ranked #360 of 438 · scores higher than 17% of peers
Bars: peers in each 10-point band of the growth score60 peers with a growth score of 10–19, including INMD · Click a bar to see the companies
Mainly because of its earnings per share growth, 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | INMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 448 reported | -6.2% | 3.4% | 24% | 33% | |
| Earnings per share growthHigher is better · 242 reported | -43.2% | 5.5% | 17% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | -6.6% | 4.6% | 20% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 360 | 6.3B CNY (≈$881M) | 14 | 44 | |
| 360 | 4.2B CNY (≈$590M) | 14 | 33 | |
| 360 | 15.7B TWD (≈$485M) | 14 | 43 | |
| 360 | 5.0B CNY (≈$706M) | 14 | 63 | |
| 360 | 810M USD | 14 | 69 | |
| 365 | 9.1B CNY (≈$1.3B) | 13 | 32 | |
| 365 | 6.0B CNY (≈$841M) | 13 | 50 | |
| 365 | 4.0B CNY (≈$561M) | 13 | 33 | |
| 365 | 11.2B CNY (≈$1.6B) | 13 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score